NFKB1 and Parkinson disease: Studies have shown that Polydatin suppresses the NF-κB pathway by activating protein kinase B (AKT)/glycogen synthase kinase-3β (GSK3β)-nuclear respiratory factor 2 (Nrf2) route, reducing loss of dopaminergic neurons in PD rats (Huang et al., 2018).